BFC Planning’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Other funds holding VERA
BFC Planning's VERA Position: Q3 2026 in Review
BFC Planning held its Vera Therapeutics (VERA) position steady in Q3 2026 at 9 shares worth $291. The position accounts for ﹤0.01% of the portfolio, ranked #3332.
BFC Planning first reported a position in VERA in Q3 2025 and has held it in 5 quarters since. The position peaked at $456 in Q4 2025. 147 funds tracked by Wall St. Rank hold VERA as of Q3 2026.
- BFC Planning held 9 shares of Vera Therapeutics worth $291 as of Q3 2026.
- BFC Planning left its Vera Therapeutics share count unchanged in Q3 2026.
- Vera Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3332 holding.
- BFC Planning first reported a position in Vera Therapeutics in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Vera Therapeutics position peaked at $456 in Q4 2025.
- 147 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.